Cite
HARVARD Citation
Taylor, J. et al. (2019). Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®. Bioorganic & medicinal chemistry letters. 29 (16), pp. 2428-2436. [Online].